Clinical Trial of Vamorolone Receives Orphan Grant Funding
https://unsplash.com/photos/lCPhGxs7pww

Clinical Trial of Vamorolone Receives Orphan Grant Funding

Funding for clinical trials can be an issue, especially for rare disease studies. Luckily, there are programs that exist to help with the financials, such as the "Clinical Studies of…

Continue Reading Clinical Trial of Vamorolone Receives Orphan Grant Funding

A Study of Chronic Fatigue Syndrome and Its Relationship to Enteroviruses

 Frontiers In Medicine recently published a critical review by Maureen Hanson and Adam O’Neal of Cornell University’s Department of Biology and Genetics. The authors searched for the cause of myalgic…

Continue Reading A Study of Chronic Fatigue Syndrome and Its Relationship to Enteroviruses

Barth Syndrome Chairman Appeals to the FDA For Appropriate Guidelines When Approving Drugs for Ultra-Rare Diseases

According to an article submitted to StatNews by members of the Barth Syndrome Foundation, the FDA approved the drug Aduhelm in accordance with its accelerated approval program. Although the treatment…

Continue Reading Barth Syndrome Chairman Appeals to the FDA For Appropriate Guidelines When Approving Drugs for Ultra-Rare Diseases
A New Prediction Model Improves Accuracy in Determining the Probability of MDS Patients’ Survival
source: pixabay.com

A New Prediction Model Improves Accuracy in Determining the Probability of MDS Patients’ Survival

The outcome of myelodysplastic syndrome (MDS) varies. The disease can lie dormant for decades, or it can become fatal in a matter of months. According to a recent article in…

Continue Reading A New Prediction Model Improves Accuracy in Determining the Probability of MDS Patients’ Survival
Alzheimer’s: Researchers Testing New Therapy to Regain Cognitive Function
source: pixabay.com

Alzheimer’s: Researchers Testing New Therapy to Regain Cognitive Function

The Arizona Bioindustry Association recently published an article stating that researchers at Arizona University are now proceeding to a Phase 2b clinical trial for a newly developed therapy for Alzheimer's. The…

Continue Reading Alzheimer’s: Researchers Testing New Therapy to Regain Cognitive Function